Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 597 |
|
|||||
| News | - | ||||||
| Day High | 3.1999 | Low High |
|||||
| Day Low | 2.85 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cyclerion Therapeutics Inc | CYCN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.21 | 7.42% | 3.04 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.86 | 2.85 | 3.1999 | 3.04 | 2.83 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 16 | 597 | US$ 3.15 | US$ 1,883 | - | 1.7501 - 6.75 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 6 | US$ 2.86 | USD |
Cyclerion Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 8.24M | 2.71M | - | 0 | -5.26M | -1.94 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cyclerion Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/26/2024 | 15:05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/11/2023 | 16:09 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 12/04/2023 | 16:09 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/04/2023 | 07:00 | GlobeNewswire Inc. | Cyclerion Appoints Regina Graul, Ph.D., as President |
| 12/01/2023 | 07:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/30/2023 | 17:16 | GlobeNewswire Inc. | Cyclerion Strengthens Board of Directors with Experienced.. |
| 11/24/2023 | 12:06 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/13/2023 | 15:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 10/23/2023 | 15:58 | Edgar (US Regulatory) | Form 8-K - Current report |
| 7/31/2023 | 06:00 | GlobeNewswire Inc. | Tisento Launches with $81 Million From Top-Tier Investor.. |
| 7/28/2023 | 15:48 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 7/19/2023 | 16:27 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CYCN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.79 | 3.1999 | 2.77 | 2.93 | 931 | 0.25 | 8.96% |
| 1 Month | 3.41 | 3.98 | 2.77 | 3.16 | 3,157 | -0.37 | -10.85% |
| 3 Months | 2.99 | 4.00 | 2.70 | 3.17 | 2,850 | 0.05 | 1.67% |
| 6 Months | 2.51 | 5.25 | 1.7501 | 3.23 | 5,368 | 0.53 | 21.12% |
| 1 Year | 5.33 | 6.75 | 1.7501 | 4.58 | 21,753 | -2.29 | -42.96% |
| 3 Years | 43.60 | 97.20 | 1.7501 | 47.53 | 276,719 | -40.56 | -93.03% |
| 5 Years | 306.40 | 349.20 | 1.7501 | 66.52 | 342,492 | -303.36 | -99.01% |
Cyclerion Therapeutics Description
| Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others. |
